The optimal treatment of patients with HER2+ breast cancer and metastatic spread to the brain

Abstract

Commentary to the trial Trastuzumab vs. lapatinib therapy in patients with HER2-positive breast cancer and brain metastases.

Keywords

• Trastuzumab
• lapatinib therapy
• breast cancer
• brain metastases